Dyne Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Dyne Therapeutics, Inc. (DYN) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-29
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$77.00K, a 122.99% decline year-over-year.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $77.00K, a 165.52% increase year-over-year.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $65.00K.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$364.00K, a 858.33% decline year-over-year.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $65.00K.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $12.00K, a 85.88% decline from fiscal 2022.
- Dyne Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $85.00K, a 57.92% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $0.00 10-Q · filed 2026-07-29 | $65.00K derived: sum of 3 quarters · filed 2026-07-29 | -$299.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $77.00K 10-Q · filed 2026-05-11 | $142.00K derived: sum of 2 quarters · filed 2026-05-11 | -$222.00K derived: sum of 3 quarters · filed 2026-05-11 | $113.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$299.00K derived: sum of 2 quarters · filed 2026-03-02 | $36.00K derived: sum of 3 quarters · filed 2026-07-29 | $65.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | -$364.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$29.00K derived: sum of 2 quarters · filed 2026-07-29 | $0.00 10-Q · filed 2025-11-05 | -$48.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $335.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $364.00K 10-Q · filed 2026-07-29 | $316.00K derived: sum of 3 quarters · filed 2026-07-29 | $364.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $29.00K 10-Q · filed 2026-05-11 | -$19.00K derived: sum of 2 quarters · filed 2026-05-11 | $29.00K derived: sum of 3 quarters · filed 2026-05-11 | $2.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | -$27.00K derived: sum of 3 quarters · filed 2026-03-02 | $0.00 10-K · filed 2026-03-02 |
| 2024-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.00K derived: sum of 2 quarters · filed 2025-11-05 | $48.00K 10-Q · filed 2025-11-05 | $33.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28 | $0.00 10-Q · filed 2025-07-28 | -$15.00K derived: sum of 3 quarters · filed 2026-03-02 | $2.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $27.00K 10-Q · filed 2025-05-08 | $12.00K derived: sum of 2 quarters · filed 2026-03-02 | $29.00K derived: sum of 3 quarters · filed 2026-03-02 | $0.00 derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $2.00K derived: sum of 2 quarters · filed 2026-03-02 | -$27.00K derived: sum of 3 quarters · filed 2026-03-02 | $12.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$12.00K derived: sum of 2 quarters · filed 2024-11-12 | $27.00K 10-Q · filed 2024-11-12 | $112.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $10.00K 10-Q · filed 2024-08-12 | $95.00K derived: sum of 3 quarters · filed 2025-02-27 | -$135.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $39.00K 10-Q · filed 2024-05-02 | $124.00K derived: sum of 2 quarters · filed 2025-02-27 | -$106.00K derived: sum of 3 quarters · filed 2025-02-27 | -$43.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$145.00K derived: sum of 2 quarters · filed 2025-02-27 | -$82.00K derived: sum of 3 quarters · filed 2025-02-27 | $85.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | -$167.00K derived: sum of 2 quarters · filed 2023-10-30 | $0.00 10-Q · filed 2023-10-30 | $41.00K derived: sum of 4 quarters · filed 2023-10-30 |
| 2022-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $230.00K 10-Q · filed 2023-08-03 | $271.00K derived: sum of 3 quarters · filed 2023-08-03 | $49.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $167.00K 10-Q · filed 2023-05-11 | $208.00K derived: sum of 2 quarters · filed 2023-05-11 | -$14.00K derived: sum of 3 quarters · filed 2023-05-11 | $310.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$181.00K derived: sum of 2 quarters · filed 2023-03-02 | $143.00K derived: sum of 3 quarters · filed 2023-03-02 | $202.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $102.00K derived: sum of 2 quarters · filed 2022-11-03 | $161.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $383.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $59.00K 10-Q · filed 2022-05-02 | |||
| 2020-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $39.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | $370.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |